AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 101 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $251,000 | +93.1% | 84,632 | -3.2% | 0.02% | +77.8% |
| Q2 2016 | $130,000 | -58.3% | 87,458 | +3.9% | 0.01% | -60.9% |
| Q1 2016 | $312,000 | -9.3% | 84,203 | +147.5% | 0.02% | -11.5% |
| Q4 2015 | $344,000 | -60.3% | 34,019 | +3.3% | 0.03% | -70.5% |
| Q3 2015 | $866,000 | +103.8% | 32,925 | +46.9% | 0.09% | +100.0% |
| Q2 2015 | $425,000 | +1.9% | 22,411 | +40.6% | 0.04% | -4.3% |
| Q1 2015 | $417,000 | – | 15,937 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |